Drug intelligence / Profile preview

Umkamin

Development stage
Unknown
Lead developer
Hanlim Pharm. Co., Ltd.
Modality
Small Molecules
Administration
Oral
01

Overview

Umkamin (also spelled Umckamin) is an herbal medicinal product developed by Hanlim Pharm. Co., Ltd., primarily indicated for the treatment of acute bronchitis. It contains an extract of the roots of *Pelargonium sidoides*, a medicinal plant native to South Africa. The extract is characterized by its complex mixture of polyphenols, coumarins, and organic acids, which contribute to its multifaceted mechanism of action. Umkamin exhibits antiviral properties by inhibiting viral entry and replication, antibacterial effects by preventing bacterial attachment to respiratory epithelial cells, and immunomodulatory activity by stimulating the production of nitric oxide and cytokines such as interferon-beta and tumor necrosis factor-alpha. Additionally, it enhances mucociliary clearance by increasing ciliary beat frequency. In clinical trials, Umkamin has been utilized as a standard-of-care active comparator to evaluate the efficacy and safety of new herbal combinations like HL301 in patients with respiratory infections.

Brand names
UmkaminUmckamin
Other names
Pelargonium sidoides extractEPs 7630EPs7630EPs-7630
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IFN-β (Interferon beta)NO2- (Nitrite)

Beyond the preview

Go deeper on Umkamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Umkamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call